Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through